000 01304 a2200385 4500
005 20250516130934.0
264 0 _c20130903
008 201309s 0 0 eng d
022 _a1476-5500
024 7 _a10.1038/cgt.2012.90
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOh, S
245 0 0 _aTransforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA.
_h[electronic resource]
260 _bCancer gene therapy
_cFeb 2013
300 _a94-100 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenoviridae
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGene Silencing
650 0 4 _aGenetic Therapy
650 0 4 _aHeLa Cells
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aRNA, Small Interfering
_xgenetics
650 0 4 _aTransforming Growth Factor beta1
_xgenetics
650 0 4 _aTransforming Growth Factor beta2
_xgenetics
700 1 _aKim, E
700 1 _aKang, D
700 1 _aKim, M
700 1 _aKim, J-H
700 1 _aSong, J J
773 0 _tCancer gene therapy
_gvol. 20
_gno. 2
_gp. 94-100
856 4 0 _uhttps://doi.org/10.1038/cgt.2012.90
_zAvailable from publisher's website
999 _c22409492
_d22409492